Cargando…

Performance of Abbott ID‐Now rapid nucleic amplification test for laboratory identification of COVID‐19 in asymptomatic emergency department patients

OBJECTIVE: We sought to evaluate the test characteristics of Abbott ID‐Now as a screening tool compared to polymerase chain reaction (PCR) testing for identification of COVID in an asymptomatic emergency department population. METHODS: We performed a prospective study enrolling a convenience sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Anu, Noble, Jeanne, Deucher, Anne, Miller, Steve, Tang, Patrick Wai, Wang, Ralph C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716572/ https://www.ncbi.nlm.nih.gov/pubmed/35005704 http://dx.doi.org/10.1002/emp2.12592

Ejemplares similares

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
por: Srivastava, Smriti, et al.
Publicado: (2022)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic review
por: Rönn, Minttu M, et al.
Publicado: (2019)

Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT)
por: Liu, Junli, et al.
Publicado: (2020)

Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan
por: Ali, Syeda M, et al.
Publicado: (2023)

Observational Research in Childhood Infectious Diseases (ORChID): a dynamic birth cohort study
por: Lambert, Stephen Bernard, et al.
Publicado: (2012)

Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective
por: Fan, Shu-Ling
Publicado: (2023)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues
por: Waggoner, Jesse J., et al.
Publicado: (2014)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients
por: Murphy, Catherine, et al.
Publicado: (2021)

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
por: Stokes, William, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection
por: Liput, Joseph R, et al.
Publicado: (2021)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test
por: Aupaix, Antoine, et al.
Publicado: (2021)

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
por: Barnacle, J.R., et al.
Publicado: (2022)

Clinical outcomes of initially asymptomatic patients with COVID-19: a Korean nationwide cohort study
por: Park, Hayne Cho, et al.
Publicado: (2021)

The Burden and Characteristics of Post-COVID-19 Conditions Among Laboratory-Confirmed Delta and Omicron COVID-19 Cases: A Preliminary Study From Maharashtra, India
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Comparison of Manual and Automated Nucleic Acid (RNA) Extraction Methods for the Detection of SARS-CoV-2 by qRT-PCR
por: Dhibika, M, et al.
Publicado: (2023)

Clinical, laboratory, and radiological features indicative of novel coronavirus disease (COVID‐19) in emergency departments: a multicenter case‐control study in Hong Kong
por: Lam, Rex Pui Kin, et al.
Publicado: (2020)

Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis
por: Pareek, Manish, et al.
Publicado: (2019)

Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study
por: Nah, Eun-Hee, et al.
Publicado: (2021)

Deimplementation strategy to reduce overtreatment of asymptomatic bacteriuria: a study protocol for a stepped-wedge cluster randomised trial
por: van Horrik, Tessa MZXK, et al.
Publicado: (2021)

Prevalence of COVID-19 Infection in Asymptomatic Cancer Patients in a District With High Prevalence of SARS-CoV-2 in Italy
por: Cavanna, Luigi, et al.
Publicado: (2021)

Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2019)

Infectious Mononucleosis: A Case Report With Unusual Features and Abnormal Laboratory Findings
por: Alli, Ammar, et al.
Publicado: (2021)

Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments
por: Kalia, Ravi, et al.
Publicado: (2022)

Laboratory-Reported Normal Value Ranges Should Not Be Used to Diagnose Periprosthetic Joint Infection
por: Forte, Salvador A, et al.
Publicado: (2022)

The Relationship Between Laboratory Findings and Mortality in COVID-19 Patients Requiring Intensive Care
por: Bahceci, Ilkay, et al.
Publicado: (2023)

Prevalence and factors associated with asymptomatic gonococcal and chlamydial infection among US Navy and Marine Corps men infected with the HIV: a cohort study
por: Carpenter, Robert J, et al.
Publicado: (2013)

A Comparative Analysis of COVID-19 IgG Antibody Level and Socio-Demographic Status in Symptomatic and Asymptomatic Population of South Andaman, India
por: Kumar, Deepak, et al.
Publicado: (2022)

Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy
por: Abraha, Iosief, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fa6kte5nesqin3vlsoasmmbrec